gene therapy (ICRT/RPMS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegene therapy (ICRT/RPMS)
Drug Alias Namecancer gene therapy (ICRT/RPMS)
ClassificationBiologics
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImperial Cancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImperial Cancer Research Technology
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A